ARS Pharmaceuticals, Inc. logo SPRY - ARS Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
1
BUY 3
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $25.50 DETAILS
HIGH: $26.00
LOW: $25.00
MEDIAN: $25.50
CONSENSUS: $25.50
UPSIDE: 211.27%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q2 2020 Q1 2019 Q4
Revenue
Revenue 22.7 28.1 32.5 15.7 8.0 86.6 2.1 0.5 0 0 0 0.0 0.0 0 0.2 0.5 0.7 0.8 0.5 2.1 2.1 0 0 0 0
Cost of Revenue 6.3 3.2 8.2 5.0 4.0 3.9 0.1 0 5.2 3.4 3.0 7.2 6.5 3.6 3.8 4.3 5.4 3.9 5.1 5.6 5.6 0.5 0.4 0.4 0.4
Gross Profit 16.4 24.9 24.3 10.7 3.9 82.7 2.0 0.5 (5.2) (3.4) (3.0) (7.2) (6.4) (3.6) (3.6) (3.9) (4.8) (3.2) (4.6) (3.5) (3.5) (0.5) (0.4) (0.4) (0.4)
Operating Expenses
R&D Expenses 4.3 3.4 2.8 4.0 3.0 3.0 4.4 6.9 5.2 3.4 3.0 7.3 6.6 4.7 3.9 4.3 5.4 3.9 5.1 5.6 5.6 8.6 5.0 4.3 6.3
SG&A Expenses 72.2 60.0 74.8 54.3 0 0 19.3 8.9 0 0 0 13.4 12.3 10.8 3.0 2.5 2.3 1.8 1.0 0.9 0.9 4.0 1.1 0.6 0.3
Other Expenses 0 3.0 0 0 38.2 32.5 0 0 2.7 3.4 12.0 (7.3) (6.6) (3.7) (3.9) (4.3) (5.4) (3.9) (5.1) (5.6) (5.6) 0 0 0 0
Operating Expenses 76.5 66.3 77.5 58.3 41.1 35.5 23.7 15.8 8.0 6.8 15.0 13.4 12.3 11.9 3.0 2.5 2.3 1.8 1.0 0.9 0.9 12.6 6.1 4.8 6.5
Operating Income
Operating Income (60.1) (41.5) (53.2) (47.6) (37.2) 47.2 (21.7) (15.3) (13.2) (10.2) (18.0) (20.6) (18.7) (15.4) (6.6) (6.3) (7.1) (5.0) (5.6) (4.4) (4.4) (13.1) (6.5) (5.2) (6.9)
Interest Expense 2.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0
Interest Income 2.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0 0 0.0 0 0 0
Profitability
EBITDA (59.7) (41.0) (48.8) (44.6) (36.9) 47.2 (21.7) (15.3) (13.2) (10.2) (18.0) (20.6) (18.7) (15.2) (6.6) (6.3) (7.0) (4.8) (5.6) (4.4) (4.4) (12.6) (6.1) (4.8) (6.5)
EBIT (60.1) (41.5) (51.2) (44.9) (37.2) 47.2 (21.7) (15.3) (13.2) (10.2) (18.0) (20.6) (18.7) (15.4) (6.6) (6.3) (7.1) (5.0) (5.6) (4.4) (4.4) (13.1) (6.5) (5.2) (6.9)
Income Before Tax (60.6) (41.4) (51.2) (44.9) (33.9) 50.2 (19.1) (12.5) (10.3) (7.2) (14.9) (17.4) (15.0) (14.4) (6.6) (6.4) (7.2) (5.1) (5.8) (4.6) (4.6) (13.1) (6.5) (5.3) (7.0)
Income Tax Expense 0 (0.1) 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (60.6) (41.3) (51.2) (44.9) (33.9) 49.9 (19.1) (12.5) (10.3) (7.2) (14.9) (17.4) (15.0) (14.4) (6.6) (6.4) (7.2) (5.1) (5.8) (4.6) (4.6) (13.1) (6.5) (5.3) (7.0)
Per Share Data
EPS (Basic) -0.61 -0.42 -0.52 -0.46 -0.35 0.51 -0.20 -0.13 -0.11 -0.07 -0.16 -0.18 -0.16 -0.15 -0.07 -0.07 -0.08 -0.15 -0.17 -0.13 -0.13 -0.38 -0.19 -0.16 -0.21
EPS (Diluted) -0.61 -0.42 -0.52 -0.46 -0.35 0.51 -0.20 -0.13 -0.11 -0.07 -0.16 -0.18 -0.16 -0.15 -0.07 -0.07 -0.08 -0.15 -0.17 -0.13 -0.13 -0.38 -0.19 -0.16 -0.21
Shares Outstanding 99.3 98.6 98.8 98.4 98.1 98.0 97.0 96.8 96.5 96.1 95.6 94.9 94.2 94.0 93.8 93.8 93.8 35.0 35.0 34.9 34.8 34.7 34.8 33.1 33.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2019 Q4
Current Assets
Cash & Cash Equivalents 24.3 41.3 59.6 51.5 39.9 50.8 39.7 36.6 56.0 71.0 60.5 119.0 87.9 210.5 37.3 44.6 234.0 60.1 300.7 359.7 374.2 386.6 10.0
Short-Term Investments 176.6 203.7 228.7 188.6 235.9 263.2 165.0 182.1 167.6 157.4 181.4 133.2 176.7 63.9 0 0 19.9 0 0 0 0 0 0
Net Receivables 28.7 25.3 36.5 26.1 10.3 9.2 1.2 0.5 0.6 0.8 0.8 0 0.5 0 0 0.0 0 0.0 0 0 0 0 0
Inventory 8.8 8.4 7.8 8.7 7.3 5.2 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 6.8 6.2 6.4 2.0 1.0 1.2 0.6 0.3 0.3 0 0 1.0 0 1.0 1.2 0 7.5 0 4.7 3.3 4.1 4.1 0.6
Total Current Assets 245.2 284.9 338.9 281.4 303.9 334.3 208.8 220.7 226.2 231.6 244.5 255.0 267.4 277.7 39.1 45.4 261.3 60.7 305.4 363.0 378.3 390.7 10.5
Non-Current Assets
Property, Plant & Equipment 2.3 2.5 2.6 2.6 1.1 1.1 0.9 0.8 0.8 0.8 0.9 0.9 1.0 0.8 0.6 0.6 6.9 0.7 6.9 3.6 3.5 3.8 4.6
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 14.2 14.5 14.7 13.2 7.5 7.7 7.9 0.4 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 44.2 0 40.3 0.3 0.3 0.3 0.6
Other Non-Current Assets 25.9 25.8 16.6 16.2 14.8 8.1 0 0 0 0.8 3.2 2.8 2.9 3.0 0.0 0.0 0 0.0 0 0 0 0 0
Total Non-Current Assets 42.3 42.8 33.9 32.0 23.5 16.9 8.8 1.2 1.3 1.6 4.1 3.7 3.8 3.7 0.6 0.7 51.1 0.7 47.2 3.9 3.9 4.1 5.1
Total Assets 287.6 327.7 372.8 313.5 327.3 351.2 217.6 222.0 227.6 233.2 248.6 258.8 271.2 281.4 39.7 46.0 312.5 61.4 352.6 367.0 382.2 394.8 15.6
Current Liabilities
Account Payables 4.7 5.7 8.4 15.6 4.1 9.9 8.3 3.3 0.8 0.8 3.0 1.5 2.6 1.7 2.5 1.9 2.6 1.8 1.7 1.8 4.4 2.6 3.5
Short-Term Debt 0.6 0.6 0.6 0 0 0 0 0 0 0.2 0.2 0 0.2 0 3.5 3.5 1.1 3.5 1.1 1.0 1.4 1.7 12.3
Deferred Revenue 0 0 0 0.7 0.5 0.6 0 0 0 0 0 0 0.0 0 0 0.3 0 1.5 0 0 0 0 0
Other Current Liabilities 44.3 32.8 41.9 4.3 4.7 2.3 2.6 1.5 1.1 1.1 5.8 0.3 5.8 1.5 0.8 0.5 11.1 0.7 12.5 12.8 5.8 5.3 2.1
Total Current Liabilities 49.6 39.1 50.9 45.6 27.6 23.4 16.6 6.7 3.7 2.4 11.2 10.1 9.8 5.4 8.3 7.5 14.8 8.2 15.3 15.5 11.6 9.6 17.9
Non-Current Liabilities
Long-Term Debt 96.5 96.4 0.9 0 0 0 0 0 0 0 0 0 0 0 2.3 3.2 0 4.9 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 79.2 76.7 173.3 73.4 69.4 69.4 0 0 0 0 0 0 0 2.9 2.9 76.1 0 76.1 0 0 0 0 0
Total Non-Current Liabilities 176.7 174.2 174.3 75.6 70.7 70.9 0 0 0 0.0 0.1 0.1 0.2 3.1 5.5 82.6 4.4 84.5 5.1 1.8 2.1 2.3 3.3
Total Liabilities 226.3 213.4 225.1 121.2 98.3 94.4 16.6 6.7 3.7 2.4 11.3 10.2 10.0 8.5 13.8 90.1 19.2 92.7 20.4 17.3 13.7 11.9 21.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (355.2) (294.6) (253.3) (202.1) (157.2) (123.3) (173.2) (154.1) (141.6) (131.3) (124.1) (109.3) (91.9) (76.9) (62.5) (55.9) (210.8) (42.3) (162.8) (140.1) (115.6) (96.7) (63.8)
Accumulated Other Comprehensive Income (0.1) 0.1 (0.0) (0.0) 0.1 0.2 0.3 (0.1) (0.1) 0.0 (0.2) (0.2) 0.1 0.4 0 0 (1.2) 0 (0.0) 0 0 0 0
Total Stockholders' Equity 61.3 114.3 147.7 192.3 229.0 256.8 201.0 215.2 223.9 230.8 237.3 248.6 261.2 272.9 25.9 (44.0) 293.2 (31.3) 332.1 349.6 368.5 382.9 (5.6)
Total Liabilities & Equity 287.6 327.7 372.8 313.5 327.3 351.2 217.6 222.0 227.6 233.2 248.6 258.8 271.2 281.4 39.7 46.0 312.5 61.4 352.6 367.0 382.2 394.8 15.6
Debt Metrics
Total Debt 97.1 97.0 1.5 1.7 0.1 0.0 0.1 0.2 0.2 0.3 0.3 0.4 0.4 0.5 6.3 7.3 5.6 9.0 6.2 2.7 3.5 4.1 15.6
Net Debt 72.8 55.6 (58.0) (49.9) (39.8) (50.8) (39.6) (36.5) (55.8) (70.7) (60.2) (118.6) (87.4) (210.0) (31.0) (37.3) (228.4) (51.0) (294.5) (357.0) (370.7) (382.5) 5.6
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q2 2020 Q1
Operating Activities
Net Income (60.6) (41.3) (51.2) (44.9) (33.9) 49.9 (19.1) (12.5) (10.3) (7.2) (14.9) (17.4) (15.0) (14.4) (6.6) (6.4) (7.2) (23.5) (22.7) (24.5) (18.9) (6.5) (5.3)
Depreciation & Amortization 0.4 (1.5) 2.4 0.3 (1.7) (1.5) 0.0 0.0 0.0 0.0 0.0 0.0 (1.8) 0.0 0.0 0.5 0.1 0.4 0.5 0.5 0.5 0.4 0.4
Stock-Based Compensation 7.4 5.7 5.7 5.4 5.3 4.3 0 3.4 3.3 2.3 2.6 0 2.2 4.8 0.5 0 0.3 0 0 0 0 0 0
Change in Working Capital 8.6 (7.5) (1.1) (1.1) (10.4) (10.7) 2.9 3.8 2.2 (10.8) 1.0 0.3 2.1 (0.8) (0.3) (1.0) 0.0 (3.4) (2.0) 5.1 1.9 0.5 (2.8)
Other Non-Cash Items (0.7) 1.1 (2.9) 0.7 0 0 1.8 (1.9) (2.0) 9.4 (1.6) 0.3 0 (10.1) 0.7 (0.1) (0.0) 5.2 5.0 4.7 4.3 0.1 0.1
Operating Cash Flow (44.9) (43.5) (47.0) (39.6) (40.7) 42.0 (14.5) (7.3) (6.7) (17.4) (12.8) (16.7) (12.4) (20.5) (5.7) (7.0) (6.9) (21.3) (19.1) (14.1) (12.2) (5.4) (7.6)
Investing Activities
Capital Expenditure 0 0 (0.2) (0.1) (0.1) (0.3) (0.1) (0.0) (0.1) 0.1 (0.0) (0.0) (0.2) (0.1) (0.0) (0.0) (0.0) (0.6) (0.1) (0.7) (0.0) (0.0) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 (25.9) 46.6 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (14.7) (48.9) (127.4) (31.4) (34.3) (163.5) (41.5) (87.6) (63.4) (34.1) (106.6) 0 (131.4) 0 0 0 0 (25.1) (40.0) 0 0 0 0
Sales/Maturities of Investments 42.5 75 88.5 80 63.5 67 61 75 55 60 60 45 20 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 (2) (5.9) 0 0 (5) (2.5) 0 0 25.9 (46.6) 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 27.8 24.1 (45.0) 48.6 29.1 (101.8) 16.8 (12.6) (8.5) 26.0 (46.6) 45.0 (111.5) (0.1) (0.0) (0.0) (0.0) (25.7) (40.1) (0.7) (0.0) (0.0) (0.0)
Financing Activities
Net Debt Issuance 0 (0.7) 97.0 0 0 0 0 0 0 0 0 0 0 (6.0) (0.9) (0.9) (0.9) 0 0 (0.5) (0.3) (0.1) (0.3)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.1 0.1 2.6 0 0 69.4 0 0 0 0 0 0 1.3 199.8 (0.6) 0 0 0 0 0 0 0 0
Financing Cash Flow 0.2 1.1 100.0 2.7 0.7 70.9 0.7 0.5 0.3 1.8 0.9 2.9 1.3 193.8 (1.6) (0.6) (0.9) 0.3 0.1 0.3 (0.1) 11.9 21.3
Cash Position
Net Change in Cash (17.0) (18.2) 8.0 11.7 (11.0) 11.2 3.0 (19.4) (15.0) 10.4 (58.5) 31.2 (122.7) 173.2 (7.3) (15.3) (7.9) (46.6) (59.0) (14.5) (12.4) 0 (10.0)
Cash at Beginning 41.3 59.6 51.5 39.9 50.8 39.7 36.6 56.0 71.0 60.5 119.0 87.9 210.5 37.3 44.6 234.0 60.1 300.7 359.7 374.2 386.6 0 10.0
Cash at End 24.3 41.3 59.6 51.5 39.9 50.8 39.7 36.6 56.0 71.0 60.5 119.0 87.9 210.5 37.3 218.7 52.2 254.0 300.7 359.7 374.2 0 0
Free Cash Flow (44.9) (43.5) (47.2) (39.6) (40.8) 41.7 (14.6) (7.3) (6.8) (17.3) (12.8) (16.7) (12.6) (20.6) (5.7) (7.0) (6.9) (21.9) (19.2) (14.8) (12.2) (5.4) (7.7)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q2 2020 Q1 2019 Q4
Income Statement
Revenue 22.7 28.1 32.5 15.7 8.0 86.6 2.1 0.5 0 0 0 0.0 0.0 0 0.2 0.5 0.7 0.8 0.5 2.1 2.1 0 0 0 0
Gross Profit 16.4 24.9 24.3 10.7 3.9 82.7 2.0 0.5 (5.2) (3.4) (3.0) (7.2) (6.4) (3.6) (3.6) (3.9) (4.8) (3.2) (4.6) (3.5) (3.5) (0.5) (0.4) (0.4) (0.4)
Operating Income (60.1) (41.5) (53.2) (47.6) (37.2) 47.2 (21.7) (15.3) (13.2) (10.2) (18.0) (20.6) (18.7) (15.4) (6.6) (6.3) (7.1) (5.0) (5.6) (4.4) (4.4) (13.1) (6.5) (5.2) (6.9)
Net Income (60.6) (41.3) (51.2) (44.9) (33.9) 49.9 (19.1) (12.5) (10.3) (7.2) (14.9) (17.4) (15.0) (14.4) (6.6) (6.4) (7.2) (5.1) (5.8) (4.6) (4.6) (13.1) (6.5) (5.3) (7.0)
EPS (Diluted) -0.61 -0.42 -0.52 -0.46 -0.35 0.51 -0.20 -0.13 -0.11 -0.07 -0.16 -0.18 -0.16 -0.15 -0.07 -0.07 -0.08 -0.15 -0.17 -0.13 -0.13 -0.38 -0.19 -0.16 -0.21
Balance Sheet
Cash & Equivalents 24.3 41.3 59.6 51.5 39.9 50.8 39.7 36.6 56.0 71.0 60.5 119.0 87.9 210.5 37.3 44.6 234.0 60.1 300.7 359.7 374.2 386.6 10.0
Total Assets 287.6 327.7 372.8 313.5 327.3 351.2 217.6 222.0 227.6 233.2 248.6 258.8 271.2 281.4 39.7 46.0 312.5 61.4 352.6 367.0 382.2 394.8 15.6
Total Debt 97.1 97.0 1.5 1.7 0.1 0.0 0.1 0.2 0.2 0.3 0.3 0.4 0.4 0.5 6.3 7.3 5.6 9.0 6.2 2.7 3.5 4.1 15.6
Stockholders' Equity 61.3 114.3 147.7 192.3 229.0 256.8 201.0 215.2 223.9 230.8 237.3 248.6 261.2 272.9 25.9 (44.0) 293.2 (31.3) 332.1 349.6 368.5 382.9 (5.6)
Cash Flow
Operating Cash Flow (44.9) (43.5) (47.0) (39.6) (40.7) 42.0 (14.5) (7.3) (6.7) (17.4) (12.8) (16.7) (12.4) (20.5) (5.7) (7.0) (6.9) (21.3) (19.1) (14.1) (12.2) (5.4) (7.6)
Capital Expenditure 0 0 (0.2) (0.1) (0.1) (0.3) (0.1) (0.0) (0.1) 0.1 (0.0) (0.0) (0.2) (0.1) (0.0) (0.0) (0.0) (0.6) (0.1) (0.7) (0.0) (0.0) (0.0)
Free Cash Flow (44.9) (43.5) (47.2) (39.6) (40.8) 41.7 (14.6) (7.3) (6.8) (17.3) (12.8) (16.7) (12.6) (20.6) (5.7) (7.0) (6.9) (21.9) (19.2) (14.8) (12.2) (5.4) (7.7)